Berkshire Hathaway discloses Teva investment

Berkshire Hathaway Inc. (NYSE:BRK-A; NYSE:BRK-B) disclosed a new stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA) on Feb. 14.

In an SEC filing issued after market close, Berkshire reported owning 18.9 million American Depositary Receipts (ADRs) of Teva as of Dec. 31, 2017. The stake is valued at $365 million based on Teva's close of $19.33...